WW International, formerly known as WeightWatchers, has filed for Chapter 11 bankruptcy protection in the United States, citing mounting debt and a dramatic decline in demand for its traditional weight-loss programmes.
The move follows the surging popularity of GLP-1 weight-loss drugs, such as Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound, which have significantly disrupted the weight management industry. Once a leader in the sector, WW International is now seeking to restructure its finances under court supervision.
Shares in the company plummeted 40% in after-hours trading on Wall Street following the announcement. The bankruptcy filing, submitted in Delaware, revealed the company holds estimated assets and liabilities between $1 billion and $10 billion.
As part of its reorganisation plan, WW aims to eliminate approximately $1.15 billion in debt. The company is reportedly working with a group of lenders to restructure its obligations and preserve operations during the process. WW’s total debt currently stands at around $1.6 billion.
Founded in the 1960s as a small weight-loss support group, WW grew into a global brand with millions of members and gained high-profile endorsements, including from media icon Oprah Winfrey, who was once one of its largest shareholders.
However, as the weight-loss landscape evolved, WW struggled to keep pace. In an effort to adapt, the company acquired a telehealth provider in 2023 to offer prescription-based weight-loss treatments. Despite this strategic pivot, WW reported a net loss of $345.7 million last year, alongside a 5.6% decline in subscription revenue.
The 2018 rebranding to WW International signaled a shift toward promoting overall wellness rather than just dieting, but this broader focus failed to counter the rapid consumer shift toward pharmaceutical solutions.
In a statement, WW said the bankruptcy protection would allow the company to restructure in a way that “strengthens its financial position and supports its transition in a rapidly evolving industry.”
The firm’s share price has fallen more than 60% since April, when the Wall Street Journal first reported that bankruptcy was being considered.
While the future of the company remains uncertain, WW’s leadership maintains that the restructuring is a necessary step to secure its long-term viability amid the rapid transformation of the weight-loss market.
